Website & contact details
- Website
Ennogen Healthcare Ltd
- Incorporated
- 14 October 2011 (15 years)
- Industry
- Manufacture of basic pharmaceutical products (21100) Wholesale of pharmaceutical goods (46460)
- Directors
- Owned by
- Ennogen Holdings Limited
- Accounts type
- Small
- Address
- Unit G4Riverside WayDartfordDA1 5BS
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 13 April 2027
- Last conf. stmt
- 30 March 2026
Charges
- Total
- 4
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 3
Officers 1 active
Officer details are public data from the Companies House register.
Director · Appointed 14 October 2011
British
Born July 1960 (66)
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Ennogen Holdings Limited
Corporate entity · Notified 1 January 2022
Owns 75–100% of shares
Private Limited Company
Former controllers (1)
1 January 2022
Ceased Gurdev Singh Rurai — Owns 75–100% of shares
Financials
Balance sheet as at 31 December 2025 · small accounts
- Net Assets
- £8,741,653
- Cash
- £273,968
- Profit
- £1,098,651
- Debt Ratio
- 5%
- Current Ratio
- 18.9x
- Return on Equity
- 13%
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £55,374 | £69,143 | £78,786 | £6,982,089 | £2,026,327 | £3,257,025 |
| Current Assets | £9,185,360 | £8,531,385 | £14,438,975 | £21,534,174 | £26,935,843 | £30,905,840 |
| Debtors | £8,658,241 | £7,228,973 | £8,741,897 | £9,809,008 | £21,848,553 | £26,373,415 |
| Cash | £273,968 | £979,994 | £4,226,501 | £7,927,047 | £42,528 | £511,979 |
| Creditors (< 1 year) | £485,236 | £940,240 | £9,845,060 | £3,479,047 | £3,170,942 | £9,353,841 |
| Creditors (> 1 year) | £0 | £65,563 | £84,230 | £1,638,368 | £1,000,000 | |
| Net Current Assets | £8,700,124 | £7,591,145 | £4,593,915 | £18,055,127 | £23,764,901 | £21,551,999 |
| Net Assets | £8,741,653 | £7,643,002 | £4,607,138 | £24,952,986 | £24,152,860 | £23,809,024 |
| Shareholder Funds | £8,741,653 | £7,643,002 | £4,607,138 | £24,952,986 | £24,152,860 | £23,809,024 |
| Turnover | £21,445,178 | £23,090,629 | ||||
| Cost of Sales | £9,096,275 | £17,095,173 | ||||
| Gross Profit | £12,348,903 | £5,995,456 | ||||
| Admin Expenses | £4,726,497 | £6,935,608 | ||||
| Staff Costs | £1,797,400 | £1,918,071 | ||||
| Operating Profit | £6,962,412 | £510,084 | ||||
| Profit Before Tax | £52,240,429 | £539,267 | ||||
| Tax | £1,186,277 | (£260,859) | ||||
| Profit for Period | £1,098,651 | £1,385,685 | £51,054,152 | £800,126 | £343,836 | £294,364 |
What Ennogen Healthcare say about themselves
“Ennogen Healthcare - We are an international pharmaceutical and medical device company, with expanding sales across international markets.”
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 3 November 2026 | Satisfaction of a charge in full |
Some other companies at this address
Other companies in this industry
Cambridge
Cheshire
Liverpool
Crewe
Edinburgh
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →